• 中文核心期刊
  • CSCD来源期刊
  • 中国科技核心期刊
  • CA、CABI、ZR收录期刊

犬细小病毒NS1蛋白原核表达及多克隆抗体制备

Prokaryotic Expression and Polyclonal Antibody of Canine Parvovirus NS1 Protein

  • 摘要:
    目的 犬细小病毒(Canine parvovirus, CPV)是犬类重要病原之一,其非结构蛋白NS1在病毒生命周期与致病性中具有关键作用。本研究旨在通过原核表达系统高效表达并纯化CPV NS1蛋白,免疫BALB/c小鼠制备高效价、高特异性NS1多克隆抗体,为分析该病毒分子作用机制提供材料基础。
    方法 设计PCR引物扩增NS1目的基因,插入pET28a(+)载体中,构建原核表达载体pET28a(+)-His-NS1。用大肠杆菌表达系统进行NS1蛋白诱导表达并进行表达条件优化,使用镍柱亲和层析进行蛋白纯化。将纯化后的NS1蛋白进行圆二色谱分析并用于BALB/c小鼠免疫,通过静脉眼眶采血获取小鼠血清进行ELISA检测、Western blot检测和激光共聚焦显微镜分析,以此评估该多克隆抗体的抗体效价及其特异性。
    结果 双酶切鉴定结果显示,pET28a(+)-His-NS1表达载体成功构建。SDS-PAGE和Western blotting结果显示,成功表达并纯化出大小约为76 kDa的NS1重组蛋白,0.1 mmol·L−1 IPTG 25 ℃条件下诱导12 h的蛋白表达最佳。圆二色谱结果显示,NS1二级结构以无规则卷曲为主,与结构预测结果相一致。使用ELISA方法测定小鼠血清效价达1∶409 600以上,说明该多克隆抗体具有良好的免疫原性;采用制备的多克隆抗体进行Western blot试验和激光共聚焦显微镜分析,结果表明其可特异性识别CPV感染细胞所产生的NS1蛋白。
    结论 本研究利用原核表达系统成功获得犬细小病毒NS1重组蛋白,并制备其鼠源多克隆抗体,为进一步研究NS1功能和致病性分子机制提供了必要条件。

     

    Abstract:
    Objective Polyclonal antibodies against the key pathogenic and viral life cycle-related NS1 of canine parvovirus (CPV) were prepared for studying the molecular mechanism of the viral infection on dogs.
    Method PCR primers were designed to amplify the non-structural NS1 gene to be inserted into the pET28a(+) vector for construction of prokaryotic expression plasmid pET28a(+)-His-NS1. Using an E. coli expression system, NS1 was expressed with the conditions optimized and protein purified by nickel ion affinity chromatography. The purified protein was then analyzed by circular dichroism spectroscopy prior to immunization on BALB/c mice. Subsequently, orbital venous serum sample of the mice was analyzed by ELISA, western blot, and confocal microscopy to determine the polyclonal antibody titer and specificity.
    Result A double enzyme digestion verified the successful construction of pET28a(+)-His-NS1 expression vector. The expressed and purified NS1 recombinant protein had a molecular weight of approximately 76 kDa. It was optimally expressed by induction with 0.1 mmol·L−1 IPTG at 25 oC for 12 h. The secondary structure of NS1 as indicated by circular dichroism spectroscopy was primarily composed of random coils and consistent with structural predictions. The polyclonal antibody in the mouse serum had a high immunogenicity with a titer exceeding 1:409 600. It was confirmed by western blot and confocal microscopy analyses to specifically recognize NS1 in the CPV-infected cells.
    Conclusion The recombinant NS1 of CPV obtained using a prokaryotic expression system in this study successfully prepared the murine polyclonal antibody that would become the essential tool to pursue previously lacked research relating to the functions of the protein and pathogenicity of CPV.

     

/

返回文章
返回